Compare Baxter International Inc (BAX) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.27B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Baxter International Inc is far larger — about 28.2× Ginkgo Bioworks Holdings Inc's market cap, and Baxter International Inc pays a 0.14% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| BAX | DNA | |
|---|---|---|
Market Cap | $14.27B | $505.73M |
Sector | Health | Health |
52-Week High | $28.35 | $16.14 |
52-Week Low | $15.80 | $5.48 |
Enterprise Value | $21.79B | $607.68M |
Dividend Yield | 0.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
